LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

Search

Alcon Inc

Gesloten

SectorGezondheidszorg

73.34 -1.49

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

73.05

Max

74.08

Belangrijke statistieken

By Trading Economics

Inkomsten

-21M

217M

Verkoop

104M

2.7B

K/W

Sectorgemiddelde

37.444

57.05

Dividendrendement

0.45

Winstmarge

7.984

Werknemers

25,942

EBITDA

-144M

521M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+30.01% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.45%

2.52%

Volgende Winsten

4 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.8B

37B

Vorige openingsprijs

74.83

Vorige sluitingsprijs

73.34

Nieuwssentiment

By Acuity

50%

50%

158 / 349 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Alcon Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 mrt 2026, 14:42 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Lensar Share Slide on Terminated Merger Deal With Alcon

16 mrt 2026, 21:37 UTC

Acquisities, Fusies, Overnames

Lensar and Alcon Agree to Terminate Merger

6 jan 2026, 15:11 UTC

Acquisities, Fusies, Overnames

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 dec 2025, 18:51 UTC

Acquisities, Fusies, Overnames

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 dec 2025, 15:54 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 dec 2025, 14:32 UTC

Acquisities, Fusies, Overnames

Alcon Upgrades Offer Price for Staar Surgical

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mrt 2026, 20:57 UTC

Acquisities, Fusies, Overnames

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

25 feb 2026, 22:29 UTC

Acquisities, Fusies, Overnames

Lensar Expects to Close Transaction in 1H of 2026 >LNSR

25 feb 2026, 22:29 UTC

Acquisities, Fusies, Overnames

Lensar, Alcon Continue to Cooperate With FTC in Connection With Request for Additional Info >LNSR

25 feb 2026, 22:28 UTC

Acquisities, Fusies, Overnames

LENSAR Provides Update on Pending Acquisition by Alcon

24 feb 2026, 21:41 UTC

Winsten

Alcon 4Q Rev $2.72B >ALC.EB

7 jan 2026, 01:00 UTC

Acquisities, Fusies, Overnames

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 jan 2026, 15:21 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 jan 2026, 14:56 UTC

Acquisities, Fusies, Overnames

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 jan 2026, 14:14 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 jan 2026, 14:14 UTC

Acquisities, Fusies, Overnames

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 jan 2026, 14:14 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 jan 2026, 14:13 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 dec 2025, 14:17 UTC

Acquisities, Fusies, Overnames

Alcon Ups Offer Price for Staar Surgical

9 dec 2025, 13:34 UTC

Acquisities, Fusies, Overnames

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 dec 2025, 13:33 UTC

Acquisities, Fusies, Overnames

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 dec 2025, 13:33 UTC

Acquisities, Fusies, Overnames

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 dec 2025, 13:33 UTC

Acquisities, Fusies, Overnames

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9 dec 2025, 13:32 UTC

Acquisities, Fusies, Overnames

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9 dec 2025, 13:32 UTC

Acquisities, Fusies, Overnames

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

Peer Vergelijking

Prijswijziging

Alcon Inc Prognose

Koersdoel

By TipRanks

30.01% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 95.35 USD  30.01%

Hoogste 118.97 USD

Laagste 75.139 USD

Gebaseerd op 14 Wall Street-analisten die 12-maands prijsdoelen bieden voor Alcon Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

14 ratings

9

Buy

4

Hold

1

Sell

Technische score

By Trading Central

95.77 / 97.61Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Strong Bullish Evidence

Sentiment

By Acuity

158 / 349 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
help-icon Live chat